{"id":134187,"date":"2024-09-23T14:01:37","date_gmt":"2024-09-23T08:31:37","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=134187"},"modified":"2024-09-23T14:01:41","modified_gmt":"2024-09-23T08:31:41","slug":"pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/","title":{"rendered":"Pharma stock jumps 4% after company announces \u20b9 10,000 Cr fundraise"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2433126557\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of this pharmaceutical stock reached a 52-week high of Rs.2,649 per share following the announcement of plans to raise Rs.10,000 crore through the issuance of Non-Convertible Debentures and Commercial Papers.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2975430679\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share Price Movement&nbsp;<\/strong><\/h2><p>In Monday&#8217;s trading session, shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/MANKIND\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Mankind Pharma Limited<\/a><\/strong> reached a 52-week high of Rs.2,649 per share, marking a 4 percent increase from its previous close of Rs.2,547.15 apiece. Over the past year, the stock has provided returns exceeding 50 percent.\u00a0<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also read<\/strong>: <strong><a href=\"https:\/\/tradebrains.in\/features\/it-stock-under-100-jumps-6-after-receiving-contracts-from-swedish-and-usa-firm\/\" target=\"_blank\" rel=\"noreferrer noopener\">IT stock under \u20b9 100 jumps 6% after receiving contracts from Swedish and USA firm<\/a><\/strong><\/p><\/blockquote><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What led to the rise&nbsp;<\/strong><\/h2><p>Drug firm Mankind Pharma Ltd announced that its board of directors approved a major fundraising initiative on 20th September. The company intends to raise Rs.10,000 crore through the private placement of non-convertible debentures (NCDs) and commercial papers (CPs).&nbsp;<\/p><p>To support this initiative, the board has established a Fund Raising Committee, which is authorized to take necessary actions, including finalizing the terms of issuance and the allotment of the NCDs and CPs.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-3819280165\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also read<\/strong>: <strong><a href=\"https:\/\/tradebrains.in\/features\/adani-group-stock-jumps-8-after-receiving-375-mil-to-expand-gas-distribution-business\/\" target=\"_blank\" rel=\"noreferrer noopener\">Adani group stock jumps 8% after receiving $375 Mil to expand gas distribution business<\/a><\/strong>\u00a0<\/p><\/blockquote><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Recent Initiatives&nbsp;<\/strong><\/h2><p>In the first week of September, Mankind Pharma announced that it had finalized a business transfer agreement (BTA) to transfer its over-the-counter (OTC) business to its wholly-owned subsidiary, Mankind Consumer Products Private Limited (MCPPL), on a slump sale basis.&nbsp;<\/p><p>In this slump sale, which involves selling the business for a lump sum without specifying individual asset and liability values, MCPPL will take over the OTC business as a going concern.&nbsp;<\/p><p>Under the deal, Mankind Pharma will divest its OTC business to Mankind Consumer Products, subject to conditions in the BTA. This move aims to streamline operations and allow Mankind Pharma to focus on its core pharmaceutical business while enhancing the management of the OTC segment.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Target Recommendation&nbsp;<\/strong><\/h2><p>Investec, a prominent brokerage firm, has recommended a \u201cBuy\u201d call on Mankind Pharma Limited with a <strong>target price of Rs.3,300 per share, indicating an upside potential of 25 percent.&nbsp;<\/strong><\/p><p>The brokerage highlighted that Mankind Pharma&#8217;s innovation-focused strategy aligns with Bharat Serums and Vaccines (BSV). It believes the market underestimates BSV&#8217;s unique advantages, projecting potential sales of $1 billion and over 35 percent EBITDA by FY32 under Mankind&#8217;s management, reflecting an improvement of over 1,000 basis points.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials&nbsp;<\/strong><\/h2><p>In its recent financial updates, Mankind Pharma reported revenue of Rs.2,893 crore in Q1FY25, marking a 12.2 percent growth from Rs.2,579 crore in Q1FY24. Similarly, the company\u2019s net profit grew to Rs.543 crore from Rs.494 crore in the same period, reflecting a 10 percent increase.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-1249396388\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Company Profile&nbsp;<\/strong><\/h2><p>Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong><em>Written by &#8211; Siddesh S Raskar&nbsp;<\/em><\/strong><\/p><\/blockquote><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-2217276097\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of this pharmaceutical stock reached a 52-week high of Rs.2,649 per share following the announcement of plans to raise Rs.10,000 crore through the issuance of Non-Convertible Debentures and Commercial Papers.&nbsp; Share Price Movement&nbsp; In Monday&#8217;s trading session, shares of Mankind Pharma Limited reached a 52-week high of Rs.2,649 per share, marking a 4 percent [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[22789,9056,22790,9055,948,936],"class_list":["post-134187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-mankind-pharma-fundraise","tag-mankind-pharma-latest-news","tag-mankind-pharma-qip","tag-mankind-pharma-share-price","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 4% after company announces \u20b9 10,000 Cr fundraise - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of this pharmaceutical stock reached a 52-week high of Rs.2,649 per share following the announcement of plans to raise Rs.10,000 crore through the issuance of Non-Convertible Debentures and Commercial Papers.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 4% after company announces \u20b9 10,000 Cr fundraise\" \/>\n<meta property=\"og:description\" content=\"Shares of this pharmaceutical stock reached a 52-week high of Rs.2,649 per share following the announcement of plans to raise Rs.10,000 crore through the issuance of Non-Convertible Debentures and Commercial Papers.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-23T08:31:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T08:31:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/\",\"name\":\"Pharma stock jumps 4% after company announces \u20b9 10,000 Cr fundraise - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-09-23T08:31:37+00:00\",\"dateModified\":\"2024-09-23T08:31:41+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of this pharmaceutical stock reached a 52-week high of Rs.2,649 per share following the announcement of plans to raise Rs.10,000 crore through the issuance of Non-Convertible Debentures and Commercial Papers.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 4% after company announces \u20b9 10,000 Cr fundraise\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 4% after company announces \u20b9 10,000 Cr fundraise - Trade Brains Features","description":"Shares of this pharmaceutical stock reached a 52-week high of Rs.2,649 per share following the announcement of plans to raise Rs.10,000 crore through the issuance of Non-Convertible Debentures and Commercial Papers.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 4% after company announces \u20b9 10,000 Cr fundraise","og_description":"Shares of this pharmaceutical stock reached a 52-week high of Rs.2,649 per share following the announcement of plans to raise Rs.10,000 crore through the issuance of Non-Convertible Debentures and Commercial Papers.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-09-23T08:31:37+00:00","article_modified_time":"2024-09-23T08:31:41+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/","name":"Pharma stock jumps 4% after company announces \u20b9 10,000 Cr fundraise - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-09-23T08:31:37+00:00","dateModified":"2024-09-23T08:31:41+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of this pharmaceutical stock reached a 52-week high of Rs.2,649 per share following the announcement of plans to raise Rs.10,000 crore through the issuance of Non-Convertible Debentures and Commercial Papers.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-4-after-company-announces-10000-cr-fundraise\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 4% after company announces \u20b9 10,000 Cr fundraise"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/134187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=134187"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/134187\/revisions"}],"predecessor-version":[{"id":134192,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/134187\/revisions\/134192"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=134187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=134187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=134187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}